Clinical trial Recruiting at 1 site Interventional Ages 18 and up

One extra structured CBT session to help cancer patients quit smoking

Official title: Effectiveness of a Cognitive Behavioral Therapy-Based Smoking Cessation Intervention Among Patients With Cancer at a Hospital in Vietnam

Run by Vietnam National Cancer Hospital · NCT07822464 · Data updated 2026-11-12

This trial tests whether adding one CBT-based smoking-cessation session to standard brief counseling helps cancer patients quit smoking cigarettes.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment446 (estimated)
SponsorVietnam National Cancer Hospital
Indiv
Locations1 site (Hanoi)
StatusRecruiting
StartedOctober 20, 2026
Main results expectedJuly 15, 2027
Study endsJuly 15, 2027
Registry record updatedOctober 26, 2026
Trial IDNCT07822464 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with cancer who smoked combustible cigarettes at diagnosis and continue smoking at screening/enrollment.

Probably not a fit

Patients who do not wish to engage in the CBT session or who cannot benefit due to clinical severity or other factors may see no additional improvement.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, two-arm study enrolls cancer patients who smoke cigarettes at diagnosis and still smoke at screening. All participants receive a brief 3-5 minute counseling session; then they are randomized to either receive one additional 20-30 minute CBT-based smoking-cessation session or no extra CBT. The trial compares abstinence rates over a 3-month follow-up period at the Vietnam National Cancer Hospital in Hanoi. It uses an intention-to-treat approach, with outcomes analyzed by original assignment even if a participant declines the extra CBT. The study aims to determine the incremental benefit of structured CBT when added to standard counseling in this population.

Why it matters

Potential benefit: If successful, patients may achieve higher quit rates and better cancer care outcomes by integrating CBT into routine smoking-cessation support.

How similar studies have gone: Previous smoking-cessation interventions with CBT have shown promise in cancer populations, but this specific add-on randomized approach is novel in this setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Aged 18 years or older.
2. Diagnosed with cancer.
3. Was smoking combustible cigarettes at the time of cancer diagnosis.
4. Still smoking combustible cigarettes at screening/enrollment.
5. Able to communicate sufficiently and provide reliable study information.
6. Provides written informed consent.

Exclusion Criteria:

1. Clinically too severe for reliable participation.
2. Cognitive/communication limitations precluding consent or reliable participation.
3. Currently participating in a competing structured smoking-cessation program.
4. Concurrent use of tobacco/nicotine products other than combustible cigarettes (e-cigarette, heated tobacco product, waterpipe/shisha, cigar, pipe, smokeless tobacco, etc.). Outside therapeutic NRT/cessation medications are not an exclusion.

Where it's running

  • Vietnam National Cancer Hospital
    Hanoi, Vietnam
    Recruiting

Study contacts

  • Principal investigator: Nguyen Duc Khoa, MD, PhD — Vietnam National Cancer Hospital
  • Study coordinator: Nguyen Duc Khoa, MD, PhD
  • Email: khoa8668@gmail.com
  • Phone: +84913022886

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.